Related references
Note: Only part of the references are listed.Drug Resistance and Pseudoresistance An Unintended Consequence of Enteric Coating Aspirin
Tilo Grosser et al.
CIRCULATION (2013)
Clinical and Genetic Association of Serum Ceruloplasmin With Cardiovascular Risk
W. H. Wilson Tang et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Genetic contribution of the leukotriene pathway to coronary artery disease
Jaana Hartiala et al.
HUMAN GENETICS (2011)
Intracellular Erythrocyte Platelet-activating Factor Acetylhydrolase I Inactivates Aspirin in Blood
Gang Zhou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Zeneng Wang et al.
NATURE (2011)
Paraoxonase-1 is a major determinant of clopidogrel efficacy
Heleen J. Bouman et al.
NATURE MEDICINE (2011)
Serum aspirin esterase is strongly associated with glucose and lipids in healthy subjects: different association patterns in subjects with type 2 diabetes mellitus
Kazuhiko Kotani et al.
DIABETOLOGY & METABOLIC SYNDROME (2010)
Aspirin Resistance Transient Laboratory Finding or Important Clinical Entity?
Eli I. Lev
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Platelet Cyclooxygenase Inhibition by Low-Dose Aspirin Is Not Reflected Consistently by Platelet Function Assays Implications for Aspirin Resistance
Francesca Santilli et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials
LANCET (2009)
Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk
Tamali Bhattacharyya et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Aspirin esterase activity - Evidence for skewed distribution in healthy volunteers
G. I. Adebayo et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2007)
Aspirin is a substrate for paraoxonase-like activity: Implications in atherosclerosis
Nalini Santanam et al.
ATHEROSCLEROSIS (2007)
Drug insight: Aspirin resistance - fact or fashion?
Carlo Patrono et al.
NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE (2007)
Increased blood plasma hydrolysis of acetylsalicylic acid in type 2 diabetic patients:: A role of plasma esterases
P Gresner et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2006)
Prevalence of aspirin resistance measured by PFA-100
I Coma-Canella et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2005)
Structure and evolution of the serum paraoxonase family of detoxifying and anti-atherosclerotic enzymes
M Harel et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2004)
Cholinesterase: phenotyping and genotyping
R Goodall
ANNALS OF CLINICAL BIOCHEMISTRY (2004)
Directed evolution of mammalian paraoxonases PON1 and PON3 for bacterial expression and catalytic specialization
A Aharoni et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Antiplatelet effect of aspirin in patients with cerebrovascular disease
MJ Alberts et al.
STROKE (2004)
Targeted disruption of intracellular type I platelet activating factor-acetylhydrolase catalytic subunits causes severe impairment in spermatogenesis
H Koizumi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Share Paper
